North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for advanced prostate cancer resistant to hormone therapy.

Giles Turner, from Brighton, is one of the men who could benefit from the drug Men with aggressive prostate cancer should be given a drug that halves their risk of death, experts have urged the NHS.

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...

Mr Streeting, who does have the power to overrule the committee, is said to now be considering the evidence and range of ...

Prostate cancer has now become the most prevalent cancer across the UK, new analysis reveals, surpassing breast cancer as the ...

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...

Former prime minister Rishi Sunak has told the BBC that a targeted prostate cancer screening programme is needed urgently, and would "save countless lives". Sunak is an ambassador for the Prostate ...

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...

Prostate Cancer UK said a 42 per cent rise in diagnoses in the past decade is thanks to increased awareness of the disease by ...